Prometheus Biosciences Inc. (RXDX)

Prometheus Biosciences Inc. (RXDX) – FDA

Dec 7, 2022 07:02 AM Prometheus Biosciences (RXDX) Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb
Jun 8, 2022 08:06 AM Prometheus Biosciences (RXDX) Reports APOLLO-CD and ARTEMIS-UC Global Phase 2 Studies Remain on Schedule
Dec 7, 2021 07:00 AM
Dec 29, 2017 07:03 AM
Oct 18, 2017 07:40 AM
Oct 18, 2017 06:10 AM
Oct 17, 2017 07:08 AM
Oct 2, 2017 05:32 PM
Sep 27, 2017 05:08 PM
Sep 11, 2017 08:02 AM
Sep 7, 2017 04:01 PM
Sep 6, 2017 08:03 AM
Jul 10, 2017 07:04 AM
May 15, 2017 07:15 AM
Apr 4, 2017 01:46 PM
Mar 30, 2017 07:06 AM
Mar 28, 2017 04:01 PM
Mar 23, 2017 04:01 PM
Feb 9, 2017 07:34 AM
Dec 2, 2016 06:33 AM
Dec 1, 2016 06:15 AM
Nov 15, 2016 07:08 AM
Aug 31, 2016 07:05 AM
Jun 6, 2016 09:13 AM
Jun 6, 2016 06:15 AM
May 24, 2016 04:03 PM
Apr 18, 2016 08:56 AM
Apr 18, 2016 07:14 AM
Apr 18, 2016 06:24 AM
Apr 7, 2016 04:05 PM
Mar 10, 2016 07:20 AM
Feb 1, 2016 09:21 AM
Dec 9, 2015 07:01 AM
Dec 8, 2015 07:01 AM
Nov 30, 2015 07:06 AM
Nov 9, 2015 06:41 AM
Nov 9, 2015 06:40 AM
Sep 17, 2015 04:01 PM
Sep 1, 2015 04:01 PM
Jun 30, 2015 07:02 AM
Jun 1, 2015 07:05 AM
Feb 17, 2015 07:49 AM
Feb 13, 2015 02:06 PM
Feb 5, 2015 09:17 AM
Dec 29, 2014 07:03 AM
Sep 15, 2014 04:01 PM